Month: September 2025

Project construction and commissioning, split between six sites across Ukraine, was completed in under six months to ensure it is ready to operate during the upcoming winter season The project uses Fluence’s Gridstack™ solution and is designed to provide 400 MWh of dispatchable energy – enough to power 600,000 homes for two hoursAMSTERDAM, Sept. 11, 2025 (GLOBE NEWSWIRE) — Fluence Energy B.V., a subsidiary of Fluence Energy, Inc. (NASDAQ: FLNC) (“Fluence”), a global market leader delivering intelligent energy storage systems, services, and asset optimization software, has energised Ukraine’s largest battery-based energy storage project with a total capacity of 200 MW together with DTEK Group, Ukraine’s largest private energy company. The project includes six battery energy storage systems of varying capacities – from...

TomTom Orbis Maps reaches 2 million charging points enabling seamless EV navigationTomTom Orbis Maps reaches 2 million charging points enabling seamless EV navigationMUNICH, Germany, Sept. 11, 2025 (GLOBE NEWSWIRE) — TomTom (TOM2), the specialist in location technology, today announced that it has mapped more than 2 million electric vehicle (EV) charging points worldwide. This milestone highlights TomTom’s commitment to supporting the shift to zero-emission driving by providing automakers with comprehensive and reliable EV navigation solutions. As EV adoption continues to rise, drivers need EV routing and navigation they can trust. TomTom combines extensive global coverage with rigorous data verification to ensure that every charging point is complete, accurate, and free of duplicates, helping car manufacturers provide...

Sampo plc, stock exchange release, 11 September 2025 at 8:30 am EEST Sampo plc’s share buybacks 10 September 2025                                                  On 10 September 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  – – AQEU    – – CEUX  – – TQEX  326,258 9.84 XHELTOTAL 326,258 9.84  * rounded to two decimals                      On 6 August 2025, Sampo announced a share buyback programme of up to a maximum of EUR 200 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated...

August was a strong month for Bigbank – loan portfolio growth continued at an above-average pace and profitability remained solid. The loan portfolio grew by 50 million euros in August. The business loan portfolio increased by 28 million euros, the home loan portfolio by 15 million euros, and the consumer loan portfolio by 7 million euros. By the end of August, the total loan portfolio reached 2.5 billion euros. The deposit portfolio grew by 19 million euros during the same period. Growth was driven by the savings deposit portfolio, which increased by 25 million euros, while the volume of term deposits decreased by 8 million euros. The trend continues, with owners of maturing term deposits reallocating funds into more flexible savings deposits. In August, Bigbank launched current accounts for retail customers in Lithuania. From now on,...

Liven Kodu 16 OÜ, a subsidiary of Liven AS (“Liven”) which is developing the Iseära project, signed a general contractor agreement with Tesron Ehitus OÜ, which is also the general contractor for the previous terraced houses in the project, for the construction of the next terraced houses. In the autumn of 2026, 30 new homes will be completed at Lutsu 5 and Koha 5-8, Harkujärve village. The volume of the construction works is nearly EUR 6 million, plus VAT. Of the 30 homes to be built, 16, or 53%, have been booked and sold to date. In the earlier phases of the Iseära project, a total of 107 homes in terraced houses and 36 homes in apartment buildings have already been completed or are nearing completion. In the coming years, there are plans to build more than 200 additional new homes. The architect of the Iseära project is ARS Projekt OÜ...

To further support its growth ambitions and enhance communication with the investment community, Wereldhave has appointed Fleur van der Erve as Director Investor Relations & Investments.  In this role, she will serve as the primary point of contact for shareholders and investment partners. Fleur brings extensive experience in the real estate sector, having previously worked at Unibail-Rodamco-Westfield and Orange Capital Partners in Amsterdam.AttachmentPR 11-09-2025 Wereldhave strengthens Investor Relations with appointment of Fleur van der Erve

IDEX Biometrics ASA today announced the launch of its new product portfolio for payment and access solutions, accompanied by a redesigned website showcasing the company’s advanced biometric authentication offerings. This launch marks a key milestone in the company’s strategic transformation and delivery on previously communicated commitments. Link: Access and payment reinvented with biometrics | IDEX Biometrics (idexbiometrics.com) “IDEX is delivering exactly as promised,” said Anders Storbråten, CEO of IDEX Biometrics. “Our new product portfolio positions us at the forefront of the global shift toward passwordless authentication. We are meeting growing demand with biometric solutions that outperform anything else on the market — in both security and user experience. With this launch, we have completed a strategic transformation:...

Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degenerationDesignation earned for a one-time intravitreal gene therapy with the potential to eliminate treatment burden for people living with neovascular age-related macular degeneration Neovascular or “wet” age-related macular degeneration can lead to significant vision loss and affects more than one million people in the USParis, September 11, 2025. The US Food and Drug Administration (FDA) has granted fast track designation to SAR402663, an investigational one-time intravitreal gene therapy for the treatment of neovascular age-related macular degeneration (AMD). The fast-track designation process aims to facilitate the development and expedite the review of medicines to treat serious conditions and fill unmet medical need. The FDA created...